James A.
About James A.
James A. is a Manufacturing Manager at Kite Pharma, where he has worked since 2021. He holds a Master of Science in Biotechnology and has extensive experience in the biopharmaceutical industry, including previous roles as a Manufacturing Supervisor and Cell Therapy Specialist II at Kite Pharma.
Work at Kite Pharma
James A. has held multiple positions at Kite Pharma, contributing to the company's advancements in cell therapy. He began his tenure as a Cell Therapy Specialist II from 2016 to 2018, where he gained experience in the intricacies of cell manufacturing processes. Following this role, he served as a Manufacturing Supervisor from 2018 to 2021, overseeing manufacturing operations and ensuring compliance with regulatory standards. In 2021, he was promoted to Manufacturing Manager, where he currently leads teams and manages production workflows, further enhancing Kite Pharma's commitment to innovative therapies.
Education and Expertise
James A. has a strong educational background in biotechnology and biology. He earned a Master of Science (M.S.) in Biotechnology from Rush University, completing his studies from 2011 to 2013. Prior to this, he obtained a Bachelor of Science (B.S.) in Biology from Morehouse College, where he studied from 2007 to 2011. Additionally, he pursued further education at UCLA Extension, earning a Certificate in Biotechnology Engineering from 2018 to 2019. This combination of formal education and practical experience has equipped him with the skills necessary for his roles in the biotechnology field.
Previous Experience in Biotechnology
Before joining Kite Pharma, James A. worked at ATCC as a Biologist from 2015 to 2016. In this role, he contributed to biological research and development, gaining valuable insights into laboratory practices and biotechnological applications. His early career also included significant experience at Kite Pharma, where he developed foundational skills in cell therapy as a Cell Therapy Specialist II from 2016 to 2018. This diverse experience has informed his current managerial role in the biotechnology sector.